Cargando…

The Impact of Colchicine on COVID-19 patients: A Clinical Trial Study

BACKGROUND: Severe acute respiratory syndrome due to COVID-19 infection has evolved into a global pandemic. This study has been designed to evaluate colchicine as an anti-inflammatory agent among COVID-19 patients regarding the disease course, duration of hospitalisation, and its morbidity and morta...

Descripción completa

Detalles Bibliográficos
Autores principales: Salehzadeh, Farhad, Pourfarzi, Farhad, Ataei, Sobhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450200/
https://www.ncbi.nlm.nih.gov/pubmed/36128202
http://dx.doi.org/10.31138/mjr.33.2.232